Festi hf.: Employee Share Option Plan – Allocation of share options to Executive management

May 2, 2025

See the attached announcements regarding the granting of stock options to executive management under the share option plan, based on Article 10 of the Income Tax Act No. 90/2003.

Attachments

Karen Ósk Gylfadóttir-tilkynning
Magnús Hafliðason-tilkynning
Kaupréttaráætlun fyrir starfsmenn Festi hf. og dótturfélaga

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Bion CEO Issues Shareholder Letter

Village Farms International Reschedules Q1 2025 Conference Call

Festi hf.: Employee Share Option Plan – Allocation of share options to Executive management

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Topics

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2025

Result of the auction of 2.25 per cent DGB 2035 and 0.25 per cent DGB 2052

HighCo: Shareholding as 04/30/2025

Related Articles

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Company

Headlines

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Newsletter